At SeromYx, our research has advanced both vaccine and antibody therapeutic development. Our publications highlight innovative approaches such as high-dimensional immune profiling and Fc effector function assays. Explore our latest work to see the science behind our platform.
Summary: Advanced Fc Effector Function Profiling to Optimize Antibody Therapeutic Safety and Efficacy
Summary: Deeper Therapeutic Antibody Developmental Insights via Comprehensive Fc Effector Function Profiling
Summary: Comprehensive Immune Profiling of Approved Anti-CD20 mAbs Using SeromYx’s Fc Effector Function Platform
Summary: Comprehensive High Throughput Fc Effector Function Profiling as a Strategy for Improved Efficacy and Safety of Antibody Therapeutics
Summary: Broad Fc effector function profiling for safer and more effective antibody therapeutics
